1

{Aprutumab: A Promising Chance for FGFR2-Driven Cancers

aprutumab-biological-rea127695
Aprutumab, {a specific therapeutic, provides {a potential breakthrough in treating cancers characterized by FGFR2 alterations. This targeted therapy functions by specifically targeting FGFR2, a protein often present in https://www.targetmol.com/compound/aprutumab
Report this page

Comments

    HTML is allowed

Who Upvoted this Story